Birmingham’s Memory Health Receives Patent for Dementia/Alzheimer’s Prevention and Treatment

Memory Health in Birmingham and Howard Foundation Holding in the United Kingdom have been issued a U.S. Patent for a product designed to prevent and treat neurodegenerative disease, or dementia.
104
Memory Health
Memory Health has been issued a U.S. patent for its dementia and Alzheimer’s treatment. // Photo courtesy of Memory Health

Memory Health in Birmingham and Howard Foundation Holding in the United Kingdom have been issued a U.S. Patent for a product designed to prevent and treat neurodegenerative disease, or dementia.

U.S. Patent 10,835,509 was issued on Nov. 17. The treatment builds on research from 2018 that shows xanthophyll carotenoids and Omega-3 fatty acids have a significant positive impact on memory, mood, and patient quality of life.

“Too many treatments and products have either failed to deliver on their promises or are promoting low level questionable science that does not achieve results,” says Edward Shehab, co-manager and partner. “Having lost my mother to Alzheimer’s and witnessed her forgetting me, my family, and the memories that filled her life, I am proud to be involved with a product based on the most impressive body of science to date and ingredients that provide real results.”

Clinical studies demonstrated the safety and efficiency of the nootropic supplement for those who have Alzheimer’s disease. It is the only treatment of its kind approved.

“The real breakthrough in Alzheimer’s disease in this decade is the demonstration that lifestyle can greatly reduce your risk: exercise, stress reduction, and nutrition all work together,” says George Perry, editor in chief of the Journal of Alzheimer’s Disease. “Carotenoids and Omega 3s are important components of a diet to reduce risk of the disease.”

Many treatments are given too late or are focused on disease modification rather than symptom remission, according to the developers.

“These are degenerative diseases, and the only logical method to address them is to provide an anti-degenerative cocktail of nutrients required by our bodies early in life in order to alter the effect of the cost of doing business with life: degeneration,” says Frederic Jouhet, co-manager and partner. “We know it is never too early to start, but science tells us it can be too late.”

This is the second patent Memory Health has received for the prevention and/or treatment of neurodegenerative disease. A similar patent was awarded for the product in the United Kingdom.

More information on the product is available here.

Facebook Comments